COVID-19 Diagnostics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global COVID-19 Diagnostics Market, By Product & Service

7.1.  COVID-19 Diagnostics Market, By Product & Service, 2020-2030

7.1.1.    Instruments

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Reagents & Kits

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Services

7.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global COVID-19 Diagnostics Market, By Sample Type

8.1.  COVID-19 Diagnostics Market, By Sample Type, 2020-2030

8.1.1.    Nasopharyngeal (NP) swabs

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Oropharyngeal (OP) swabs

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Nasal swabs

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Blood

8.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global COVID-19 Diagnostics Market, By Test Type

9.1.  COVID-19 Diagnostics Market, By Test Type, 2020-2030

9.1.1.    Molecular (PCR) Testing

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Antigen-based Testing

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Antibody (Serology) Testing

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Others

9.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global COVID-19 Diagnostics Market, By Mode Type

10.1.        COVID-19 Diagnostics Market, By Mode Type, 2020-2030

10.1.1.  Point-of-Care (PoC)

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Non Point-of-Care (Non-PoC)

10.1.2.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global COVID-19 Diagnostics Market, By End-use Type

11.1.        COVID-19 Diagnostics Market, By End-use, 2020-2030

11.1.1.  Laboratories

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Hospitals

11.1.2.1.      Market Revenue and Forecast (2016-2030)

11.1.3.  Diagnostic Centers and Clinics

11.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global COVID-19 Diagnostics  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, By Product & Service (2016-2030)

12.1.2.  Market Revenue and Forecast, By Sample Type (2016-2030)

12.1.3.  Market Revenue and Forecast, By Test Type (2016-2030)

12.1.4.  Market Revenue and Forecast, By Mode (2016-2030)

12.1.5.  Market Revenue and Forecast, By End-use (2016-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, By Product & Service (2016-2030)

12.1.6.2.      Market Revenue and Forecast, By Sample Type (2016-2030)

12.1.6.3.      Market Revenue and Forecast, By Test Type (2016-2030)

12.1.6.4.      Market Revenue and Forecast, By Mode (2016-2030)

12.1.7.  Market Revenue and Forecast, By End-use (2016-2030)

12.1.8.  Rest of North America

12.1.8.1.      Market Revenue and Forecast, By Product & Service (2016-2030)

12.1.8.2.      Market Revenue and Forecast, By Sample Type (2016-2030)

12.1.8.3.      Market Revenue and Forecast, By Test Type (2016-2030)

12.1.8.4.      Market Revenue and Forecast, By Mode (2016-2030)

12.1.8.5.      Market Revenue and Forecast, By End-use (2016-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, By Product & Service (2016-2030)

12.2.2.  Market Revenue and Forecast, By Sample Type (2016-2030)

12.2.3.  Market Revenue and Forecast, By Test Type (2016-2030)

12.2.4.  Market Revenue and Forecast, By Mode (2016-2030)

12.2.5.  Market Revenue and Forecast, By End-use (2016-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, By Product & Service (2016-2030)

12.2.6.2.      Market Revenue and Forecast, By Sample Type (2016-2030)

12.2.6.3.      Market Revenue and Forecast, By Test Type (2016-2030)

12.2.7.  Market Revenue and Forecast, By Mode (2016-2030)

12.2.8.  Market Revenue and Forecast, By End-use (2016-2030)

12.2.9.  Germany

12.2.9.1.      Market Revenue and Forecast, By Product & Service (2016-2030)

12.2.9.2.      Market Revenue and Forecast, By Sample Type (2016-2030)

12.2.9.3.      Market Revenue and Forecast, By Test Type (2016-2030)

12.2.10.               Market Revenue and Forecast, By Mode (2016-2030)

12.2.11.               Market Revenue and Forecast, By End-use (2016-2030)

12.2.12.               France

12.2.12.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.2.12.2.   Market Revenue and Forecast, By Sample Type (2016-2030)

12.2.12.3.   Market Revenue and Forecast, By Test Type (2016-2030)

12.2.12.4.   Market Revenue and Forecast, By Mode (2016-2030)

12.2.13.               Market Revenue and Forecast, By End-use (2016-2030)

12.2.14.               Rest of Europe

12.2.14.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.2.14.2.   Market Revenue and Forecast, By Sample Type (2016-2030)

12.2.14.3.   Market Revenue and Forecast, By Test Type (2016-2030)

12.2.14.4.   Market Revenue and Forecast, By Mode (2016-2030)

12.2.15.               Market Revenue and Forecast, By End-use (2016-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, By Product & Service (2016-2030)

12.3.2.  Market Revenue and Forecast, By Sample Type (2016-2030)

12.3.3.  Market Revenue and Forecast, By Test Type (2016-2030)

12.3.4.  Market Revenue and Forecast, By Mode (2016-2030)

12.3.5.  Market Revenue and Forecast, By End-use (2016-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, By Product & Service (2016-2030)

12.3.6.2.      Market Revenue and Forecast, By Sample Type (2016-2030)

12.3.6.3.      Market Revenue and Forecast, By Test Type (2016-2030)

12.3.6.4.      Market Revenue and Forecast, By Mode (2016-2030)

12.3.7.  Market Revenue and Forecast, By End-use (2016-2030)

12.3.8.  China

12.3.8.1.      Market Revenue and Forecast, By Product & Service (2016-2030)

12.3.8.2.      Market Revenue and Forecast, By Sample Type (2016-2030)

12.3.8.3.      Market Revenue and Forecast, By Test Type (2016-2030)

12.3.8.4.      Market Revenue and Forecast, By Mode (2016-2030)

12.3.9.  Market Revenue and Forecast, By End-use (2016-2030)

12.3.10.               Japan

12.3.10.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.3.10.2.   Market Revenue and Forecast, By Sample Type (2016-2030)

12.3.10.3.   Market Revenue and Forecast, By Test Type (2016-2030)

12.3.10.4.   Market Revenue and Forecast, By Mode (2016-2030)

12.3.10.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.3.11.               Rest of APAC

12.3.11.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.3.11.2.   Market Revenue and Forecast, By Sample Type (2016-2030)

12.3.11.3.   Market Revenue and Forecast, By Test Type (2016-2030)

12.3.11.4.   Market Revenue and Forecast, By Mode (2016-2030)

12.3.11.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, By Product & Service (2016-2030)

12.4.2.  Market Revenue and Forecast, By Sample Type (2016-2030)

12.4.3.  Market Revenue and Forecast, By Test Type (2016-2030)

12.4.4.  Market Revenue and Forecast, By Mode (2016-2030)

12.4.5.  Market Revenue and Forecast, By End-use (2016-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, By Product & Service (2016-2030)

12.4.6.2.      Market Revenue and Forecast, By Sample Type (2016-2030)

12.4.6.3.      Market Revenue and Forecast, By Test Type (2016-2030)

12.4.6.4.      Market Revenue and Forecast, By Mode (2016-2030)

12.4.7.  Market Revenue and Forecast, By End-use (2016-2030)

12.4.8.  North Africa

12.4.8.1.      Market Revenue and Forecast, By Product & Service (2016-2030)

12.4.8.2.      Market Revenue and Forecast, By Sample Type (2016-2030)

12.4.8.3.      Market Revenue and Forecast, By Test Type (2016-2030)

12.4.8.4.      Market Revenue and Forecast, By Mode (2016-2030)

12.4.9.  Market Revenue and Forecast, By End-use (2016-2030)

12.4.10.               South Africa

12.4.10.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.4.10.2.   Market Revenue and Forecast, By Sample Type (2016-2030)

12.4.10.3.   Market Revenue and Forecast, By Test Type (2016-2030)

12.4.10.4.   Market Revenue and Forecast, By Mode (2016-2030)

12.4.10.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.4.11.               Rest of MEA

12.4.11.1.   Market Revenue and Forecast, By Product & Service (2016-2030)

12.4.11.2.   Market Revenue and Forecast, By Sample Type (2016-2030)

12.4.11.3.   Market Revenue and Forecast, By Test Type (2016-2030)

12.4.11.4.   Market Revenue and Forecast, By Mode (2016-2030)

12.4.11.5.   Market Revenue and Forecast, By End-use (2016-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, By Product & Service (2016-2030)

12.5.2.  Market Revenue and Forecast, By Sample Type (2016-2030)

12.5.3.  Market Revenue and Forecast, By Test Type (2016-2030)

12.5.4.  Market Revenue and Forecast, By Mode (2016-2030)

12.5.5.  Market Revenue and Forecast, By End-use (2016-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, By Product & Service (2016-2030)

12.5.6.2.      Market Revenue and Forecast, By Sample Type (2016-2030)

12.5.6.3.      Market Revenue and Forecast, By Test Type (2016-2030)

12.5.6.4.      Market Revenue and Forecast, By Mode (2016-2030)

12.5.7.  Market Revenue and Forecast, By End-use (2016-2030)

12.5.8.  Rest of LATAM

12.5.8.1.      Market Revenue and Forecast, By Product & Service (2016-2030)

12.5.8.2.      Market Revenue and Forecast, By Sample Type (2016-2030)

12.5.8.3.      Market Revenue and Forecast, By Test Type (2016-2030)

12.5.8.4.      Market Revenue and Forecast, By Mode (2016-2030)

12.5.8.5.      Market Revenue and Forecast, By End-use (2016-2030)

Chapter 13.  Company Profiles

13.1.              Hologic Inc

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Thermo Fisher Scientific, Inc.

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              F. Hoffman-La Roche Ltd.

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Perkin Elmer, Inc

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Veredus Laboratories

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              1drop Inc

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              ADT Biotech Sdn Bhd

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Laboratory Corporation of America Holdings

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              bioMérieux SA.

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           Danaher

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

13.11.           Mylab Discovery Solutions Pvt. Ltd.

13.11.1.               Company Overview

13.11.2.               Product Offerings

13.11.3.               Financial Performance

13.11.4.               Recent Initiatives

13.12.           Neuberg Diagnostics

13.12.1.               Company Overview

13.12.2.               Product Offerings

13.12.3.               Financial Performance

13.12.4.               Recent Initiatives

13.13.           ALDATU BIOSCIENCES

13.13.1.               Company Overview

13.13.2.               Product Offerings

13.13.3.               Financial Performance

13.13.4.               Recent Initiatives

13.14.           Quidel Corporation.

13.14.1.               Company Overview

13.14.2.               Product Offerings

13.14.3.               Financial Performance

13.14.4.               Recent Initiatives

13.15.           Quest Diagnostics

13.15.1.               Company Overview

13.15.2.               Product Offerings

13.15.3.               Financial Performance

13.15.4.               Recent Initiatives

13.16.           Abbott

13.16.1.               Company Overview

13.16.2.               Product Offerings

13.16.3.               Financial Performance

13.16.4.               Recent Initiatives

13.17.           altona Diagnostics GmbH

13.17.1.               Company Overview

13.17.2.               Product Offerings

13.17.3.               Financial Performance

13.17.4.               Recent Initiatives

13.18.           Luminex Corporation

13.18.1.               Company Overview

13.18.2.               Product Offerings

13.18.3.               Financial Performance

13.18.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms